New Jersey bills · 2026-2027 Regular Session
New Jersey A 4852
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Katz, Andrea (Democratic)
- Sweeney, Marisa
- Kearney, Vincent M.
- Tully, Chris (Democratic)
- Vitale, Joseph F. (Democratic)
- Gopal, Vin (Democratic)
- Mukherji, Raj (Democratic)
Cosponsors (2)
- Karabinchak, Robert J. (Democratic)
- Donlon, Margie, M.D.
Summary
No official summary is available for this bill.
Latest action(Jul 8, 2026): Approved P.L.2026, c.40.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jul 8, 2026 · House
Approved P.L.2026, c.40. - Jun 30, 2026 · Senate
Passed Senate (Passed Both Houses) (38-2) - Jun 30, 2026 · House
Substituted for S4194/4210 (SCS) - Jun 30, 2026 · Senate
Received in the Senate without Reference, 2nd Reading - Jun 30, 2026 · House
Passed by the Assembly (76-2-1) - Jun 23, 2026 · House
Reported from Assembly Comm. as a Substitute, 2nd Reading - Jun 23, 2026 · House
Transferred to Assembly State and Local Government Committee - May 4, 2026 · House
Introduced, Referred to Assembly Health Committee